Approval · Notice of Compliance 30577 · 2023
ETOMIDATE INJECTION, USP: Notice of Compliance 30577
Issued April 26, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30577
- Date
- April 26, 2023
- Company
- Fresenius Kabi Canada LtdToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- TOMVU (Sterimax Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ETOMIDATE INJECTION, USP | Not yet assigned | — |
Medicinal ingredients
- ETOMIDATE 2 MG per ML